ICD-10 Coding for PCOS Patients Undergoing ART

Polycystic ovary syndrome is present in 15 to 20 percent of fertility patients and is the underlying diagnosis for a significant proportion of IVF, IUI, and medicated FET cycles. Despite its prevalence, PCOS is one of the most inconsistently coded diagnoses in fertility billing. Practices default to N97.0 (ovulatory infertility) or N97.9 (unspecified) instead of using the PCOS-specific code, and they frequently omit the sequencing that supports medical necessity at the payer level.

The Primary ICD-10 Code for PCOS

The ICD-10-CM code for polycystic ovary syndrome is E28.2. This is the correct primary diagnosis code when the patient's infertility is attributable to PCOS — not N97.0, and not Z31.83 alone. E28.2 is classified under E28.x (ovarian dysfunction), not N97.x (female infertility), which is why practices that default to the N97.x series miss it entirely.

How to Sequence PCOS With Infertility Codes

For a PCOS patient undergoing ART, the correct code sequencing for the procedure encounter is: E28.2 as the primary diagnosis, N97.0 as an additional code (ovulatory infertility — the mechanism through which PCOS causes infertility), and Z31.83 as the encounter code. This three-code combination tells the full clinical story: the patient has PCOS, which causes anovulatory infertility, and this is an ART cycle encounter.

OHSS Coding for PCOS Patients

PCOS patients carry a significantly elevated risk of ovarian hyperstimulation syndrome. If OHSS develops during or after an IVF cycle, the correct code is N98.1 — hyperstimulation of ovaries. This is a complication code and should be sequenced as an additional code after the primary PCOS and infertility codes. For a cycle cancelled due to OHSS risk, document the cancellation reason clearly and add N98.1 as an additional diagnosis. The S4021 or S4022 S-code (cancelled cycle before or after retrieval) may also apply for fertility mandate payers.

PCOS Comorbidity Codes to Know

• E66.9 — Obesity, unspecified (when BMI meets clinical obesity threshold and is documented)
• E11.x — Type 2 diabetes mellitus (when PCOS-associated insulin resistance has progressed to clinical diabetes)
• E28.1 — Androgen excess (when hyperandrogenism is separately documented as a clinical finding)
• N91.2 — Amenorrhea, unspecified (when cycle irregularity is the presenting symptom driving the encounter)
• N98.1 — Ovarian hyperstimulation syndrome (as an additional code when OHSS is documented)

How Payers Read PCOS-Coded Claims Differently

The same E28.2 → N97.0 → Z31.83 code set produces very different payer responses depending on plan design. Mandate-state fully-insured plans generally treat E28.2 with N97.0 sequencing as documented infertility qualifying for statutory coverage of medically diagnosed anovulatory disease. Non-mandate fully-insured plans often exclude infertility treatment even with clear PCOS documentation, though non-fertility PCOS management — menstrual regulation, metabolic screening, hirsutism management — may remain covered under the standard medical benefit. Self-funded ERISA plans vary entirely by employer election: the same E28.2 diagnosis unlocks full ART coverage at one employer and yields a hard exclusion at another with an identical ICD-10 sequence.

Fertility benefit managers such as Progyny, WINFertility, Carrot, and Maven Clinic treat PCOS as one of the strongest medical-necessity anchors in their authorization review, because it documents an anovulatory mechanism rather than an unexplained-infertility workup. Medicaid coverage varies by state — PCOS diagnosis and management (menstrual regulation, metformin for insulin resistance) is often covered even in states where ART itself is excluded, so verify the PCOS management line separately from the ART line before writing off a mixed claim.

Documentation That Supports the E28.2 Diagnosis

Payer medical-necessity review examines the Rotterdam diagnostic framework rather than a raw E28.2 line item. The 2003 Rotterdam consensus criteria (reaffirmed in the 2018 international evidence-based PCOS guideline) require two of three findings: oligo- or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. The clinical workup that supports this framework typically includes AMH, FSH, LH, total and free testosterone, DHEA-S, SHBG, prolactin, TSH, 17-hydroxyprogesterone to exclude non-classic congenital adrenal hyperplasia, and a fasting glucose and insulin panel to characterize metabolic status.

Ultrasound findings supporting polycystic ovarian morphology follow the 2018 threshold: 20 or more follicles measuring 2 to 9 mm per ovary on a transvaginal probe with adequate resolution, or an ovarian volume greater than 10 mL. Document the exclusion of alternative causes — thyroid dysfunction, hyperprolactinemia, non-classic CAH, Cushing syndrome, androgen-secreting tumors — explicitly in the record, and include a clinical note that ties the anovulatory infertility (N97.0) to the underlying PCOS diagnosis (E28.2). The stronger the workup documentation, the harder it is for a payer reviewer to reclassify an E28.2 encounter as diagnostic testing rather than treatment.

Reading PCOS-Related Denials by CARC Code

When a PCOS-coded claim returns with a denial, the CARC code identifies the specific recovery path. CO-11 (diagnosis inconsistent with procedure) frequently appears when E28.2 is paired with Z31.41 (procreative investigation) rather than Z31.83 (ART encounter), or when only Z31.83 is present without the anovulatory infertility sequence. The fix is a corrected claim with the E28.2 → N97.0 → Z31.83 sequence intact. CO-16 (claim or service lacks information) indicates the PCOS documentation submitted did not substantiate medical necessity for the specific procedure; attach the Rotterdam-criteria clinical note and lab panel and resubmit. CO-96 (non-covered benefit) reflects a plan-level infertility exclusion rather than a coding error — verify whether the plan carves out fertility to an FBM before treating the denial as final.

CO-197 (authorization required or authorization mismatch) responds well to a re-auth appeal that explicitly references the E28.2 documentation and the medical-necessity language in the plan document. PR-49 (routine or preventive) means the encounter was classified as annual gynecologic care rather than a fertility service; re-sequence with Z31.83 primary if the encounter is an ART cycle service and the ovulation-induction or monitoring codes are on the claim. PR-119 (benefit maximum reached) signals a mandate cycle-cap or plan dollar-cap exhaustion; the E28.2 documentation supports a medical-exception appeal only on plans whose cycle-cap language allows for medically necessary exceptions, so read the plan document before drafting.

How Fertility Benefit Managers Use the PCOS Diagnosis

Fertility benefit managers treat PCOS as a stronger medical-necessity anchor than an unexplained-infertility workup because it establishes a documented anovulatory pathology that a fertility treatment directly addresses. Progyny's Smart Cycle authorization framework accepts PCOS documentation as evidence of a treatment target rather than a diagnostic-testing phase, which typically shortens the initial review cycle. WINFertility's clinical-navigation model relies on documented anovulatory pathology, and a Rotterdam-supported E28.2 diagnosis usually shortens the clinical-review phase of authorization.

Carrot Fertility's benefit administration applies medical-necessity language rather than diagnostic-workup criteria, so PCOS documentation is treated as an established diagnosis rather than a workup finding. Maven Clinic's virtual-navigation model routes PCOS patients into a specific care pathway based on the E28.2 diagnosis in the clinical note. For every FBM, the documentation submitted at authorization should include the Rotterdam-criteria evidence — labs, ultrasound findings, exclusion of alternative causes — so medical-necessity review does not need to request additional documentation and delay the cycle start.

Building a PCOS Code Set Template

Create a charge entry template or EHR smart set for PCOS patients that defaults to E28.2 as the primary diagnosis and prompts the coder to add the ovulatory infertility code, the encounter code, and any documented comorbidities. This prevents the default-to-N97.9 pattern that leaves medical necessity gaps and can trigger payer review at any insurer that expects PCOS to be coded with E28.2 rather than an unspecified infertility code.